Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb, Randomized, Double-blind, Placebo-controlled Study in Parallel Groups Assessing the Efficacy and Safety of Two Doses of SOM3355 in Patients Suffering From Huntington's Disease With Choreic Movements

NCT05475483 is registered in ClinicalTrials.gov with SOM Innovation Biotech SA as lead sponsor.

NCT NCT05475483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05475483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb, Randomized, Double-blind, Placebo-controlled Study in Parallel Groups Assessing the Efficacy and Safety of Two Doses of SOM3355 in Patients Suffering From Huntington's Disease With Choreic Movements
Lead sponsor
SOM Innovation Biotech SA
Phase
Phase 2
Overall status
Completed
Start date
August 2, 2022
Completion date
July 15, 2024
Enrollment
139 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

huntington chorea